跳至主要内容
临床试验/NCT03216759
NCT03216759Unknown不适用

Effects of Comprehensive Intestinal Protection Strategy on Postoperative Intestinal Complications in Patients Undergoing Laparotomy With General Anesthesia

Nanfang Hospital, Southern Medical University0 个研究点目标入组 182 人开始时间: 2017年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
182
主要终点
The incidence of digestive system complications after operation

研究概览

简要总结

To investigate the morbidity of intestinal injury after open surgery and observe the effect of comprehensive intestinal protection strategy on postoperative intestinal complications in patients undergoing laparotomy with general anesthesia.

详细描述

Perioperative intestinal injury is one of the common tissues and organs injury in surgical practice. However, there is a lack of effective means of prevention and treatment.The investigators previously found that ischemic preconditioning, IPC, and dexmedetomidine has protective effects on intestinal mucosal injury.

However, the combined effect of various factors has not been clinically validated. To explore the effect of comprehensive intestinal protection strategy on postoperative intestinal complications in patients undergoing laparotomy with general anesthesia,the investigators select the patients undergoing open surgery under general anesthesia as the study subjects and the concentration of intestinal fatty acid binding protein (I-FABP) as well as the incidence of digestive system complications in one week after operation are the main observation indexes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged between 18 and 70 years;
  • Elective abdominal surgery under general anesthesia, operation time > 2h;
  • ASA Ⅰ ~ Ⅲ;
  • Patient informed and consent to accept the test.

排除标准

  • persons under the age of 18 or over 70 years old;
  • pregnant or lactating women;
  • combined with lung, liver, kidney, cardiovascular and hematopoietic system disease and other serious primary disease;
  • preoperative Hb <7g / l;
  • oral sulfa drugs or nicorandil antihypertensive drugs;
  • lower extremity amputees;
  • with peripheral vascular disease;
  • patients with mental illness or severe neurosis;
  • can not express the subjective symptoms;
  • nearly 3 months to participate in other drug clinical trials;
  • within 3 months of receiving other surgical treatment.

研究组 & 干预措施

intervention

Experimental
  1. After the anesthesia induction and before surgery,the patient's left upper limb was subjected to ischemic preconditioning.
  2. At the beginning of anesthesia induction, 3 μg / kg / h of dexmedetomidine was infused and adjusted to 0.3 ug / kg / h after 10 min of infusion until 30 minutes before the end of the procedure.
  3. Before the induction of anesthesia, the steel wire epidural catheter was placed in the T8-9 or T10-11 gap.

干预措施: Ischemic preconditioning (Procedure)

intervention

Experimental
  1. After the anesthesia induction and before surgery,the patient's left upper limb was subjected to ischemic preconditioning.
  2. At the beginning of anesthesia induction, 3 μg / kg / h of dexmedetomidine was infused and adjusted to 0.3 ug / kg / h after 10 min of infusion until 30 minutes before the end of the procedure.
  3. Before the induction of anesthesia, the steel wire epidural catheter was placed in the T8-9 or T10-11 gap.

干预措施: Dexmedetomidine (Drug)

intervention

Experimental
  1. After the anesthesia induction and before surgery,the patient's left upper limb was subjected to ischemic preconditioning.
  2. At the beginning of anesthesia induction, 3 μg / kg / h of dexmedetomidine was infused and adjusted to 0.3 ug / kg / h after 10 min of infusion until 30 minutes before the end of the procedure.
  3. Before the induction of anesthesia, the steel wire epidural catheter was placed in the T8-9 or T10-11 gap.

干预措施: Patient-controlled epidural analgesia (Procedure)

结局指标

主要结局

The incidence of digestive system complications after operation

时间窗: 12 hours to one week after surgery

The incidence of digestive system complications within one week after surgery

The concentration of intestinal fatty acid-binding protein (I-FABP)

时间窗: 12 h after operation

The concentration of intestinal fatty acid-binding protein (I-FABP) at 12 h after operation

次要结局

  • Postoperative heart and respiratory complications within one week(12 hours to one week after surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kexuan Liu

Director, Head of Anesthesiology, Principal Investigator, Clinical Professor

Nanfang Hospital, Southern Medical University

相似试验

Effects of Comprehensive Intestinal Protection... | 临床试验